National Cancer Institute: Surveillance, Epidemiology, and End Results: Populations (1969–2010). http://seer.cancer.gov.
Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–34.
Article
CAS
PubMed
Google Scholar
Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma. 2006;47:1477–80.
Article
PubMed
Google Scholar
Catovsky D, Wade R, Else M. The clinical significance of patients' sex in chronic lymphocytic leukemia. Haematologica. 2014;99(6):1088–94.
Article
PubMed
PubMed Central
Google Scholar
Hallek M. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Am J Hematol. 2015;90(5):446–60.
Article
CAS
PubMed
Google Scholar
Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219–34.
CAS
PubMed
Google Scholar
Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198–204.
Article
CAS
PubMed
Google Scholar
Cramer P, Hallek M. Prognostic factors in chronic lymphocytic leukemia. « what do we need to know? ». Nat Rev Clin Oncol. 2011;8:38–47.
Article
CAS
PubMed
Google Scholar
Rosenquist R, Cortese D, Bhoi S, Mansouri L, Gunnarsson R. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? Leuk Lymphoma. 2013;54(11):2351–64.
Article
CAS
PubMed
Google Scholar
Salawu L, Bolarinwa RA, Durosinmi MA. Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria. Afr Health Sci. 2010;10(2):187–92.
CAS
PubMed
PubMed Central
Google Scholar
Omoti CE, Awodu OA, Bazuaye GN. Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria. Int J Lab Hematol. 2007;29(6):426–32.
Article
CAS
PubMed
Google Scholar
Müller-Hermelink HK, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris NL et al. editors. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC 4th Edition; 2008. pp 180–182.
Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640–5.
CAS
PubMed
Google Scholar
Shamebo M, Gebremedhin A. Chronic lymphocytic leukaemia in Ethiopians. East Afr Med J. 1996;73(10):643–6.
CAS
PubMed
Google Scholar
Pfeil AM, Imfeld P, Pettengell R, Jick SS, Szucs TD, Meier CR, Schwenkglenks M. Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD). Ann Hematol. 2015;94(3):421–9.
Article
CAS
PubMed
Google Scholar
Projections de l’incidence et de la mortalité par cancer en France en 2011. Cancers/Surveillance épidémiologique des cancers/Projections Estimations de l’incidence et de la mortalité en France en 2011.
Fleming AF, Terunuma H, Tembo C, et al. Leukaemias in Zambia. Leukaemia. 1999;13:1292–3.
Article
CAS
Google Scholar
Molica S, Mauro FR, Callea V, Gentile M, Giannarelli D, Lopez M, et al. GIMEMA CLL Study Group. A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lympho- cytic leukemia. Leuk Lymphoma. 2005;46(4):553–60.
Article
PubMed
Google Scholar
Chen C, Puvvada S. Prognostic Factors for Chronic Lymphocytic Leukemia. Curr Hematol Malig Rep. 2016;11(1):37–42.
Article
PubMed
Google Scholar
Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev. 2008;88(3):841–86.
Article
CAS
PubMed
Google Scholar
Funaro A, Morra M, Calosso L, Zini MG, Ausiello CM. Malavasi F Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens. 1997;49(1):7–15.
Article
CAS
PubMed
Google Scholar
Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840–47.
CAS
PubMed
Google Scholar
Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood. 2001;98(9):2633–39.
Article
PubMed
Google Scholar
Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99(3):1023–9.
Article
CAS
PubMed
Google Scholar
Durig J, Naschar M, Schmucker U, Renzing-Kohler K, Holter T, Huttmann A, Duhrsen U. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leuk Off J Leuk Soc Am Leuk Res Fund UK. 2002;16(1):30–5.
Article
CAS
Google Scholar
Thornton PD, Fernandez C, Giustolisi GM, Morilla R, Atkinson S, A’Hern RP, Matutes E, Catovsky D. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. Hematol J: Off J Eur Haematol Assoc/EHA. 2004;5(2):145–51.
Article
CAS
Google Scholar
Garg R, Wierda W, Ferrajoli A, Abruzzo L, Pierce S, Lerner S, Keating M, O'Brien S. The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia. Cancer. 2012;118(14):3531–7.
Article
CAS
PubMed
Google Scholar
Ouillette P, Erba H, Kujawski L, et al. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res. 2008;68:1012–21.
Article
CAS
PubMed
Google Scholar
Parker H, Rose-Zerilli MJ, Parker A, et al. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Leukemia. 2011;25:489–97.
Article
CAS
PubMed
Google Scholar
Gunnarsson R, Mansouri L, Isaksson A, et al. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica. 2011;96:1161–9.
Article
PubMed
PubMed Central
Google Scholar
Smolewski P, Witkowska M, Korycka-Wołowiec A. New insights into biology, prognostic factors, and current therapeutic strategies in chronic lymphocytic leukemia. ISRN Oncol 2013: 740615. 740615. doi: 10.1155/2013/740615.
Hallek M. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment. Am J Hematol. 2013;88(9):803–16.
Article
CAS
PubMed
Google Scholar
Lai YY, Huang XJ. Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study. Chin Med J. 2011;124(16):2417–22.
PubMed
Google Scholar
Shvidel L, Bairey O, Tadmor T, Braester A, Ruchlemer R, Fineman R, Joffe E, Berrebi A, Polliack A. Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemia. Anticancer Res. 2015;35(5):2861–6.
PubMed
Google Scholar